SPRAGUE JOHN M (Chief Financial Officer) purchased 7.0% of their position (10K shares) of T2 BIOSYSTEMS, INC. on the open market
Open‑market purchase worth $4.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/11/2022ACC: 0000899243-22-014414
Officer· Chief Financial Officer
Since Jul 2018
+10K
Net shares
Net buyer
$4.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$0.48
Trade value
$4.77K
% of position
7.0%
4/8/2022
142.35K→152.35K
Total
Net shares
+10K
Net value
$4.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2022 | P · Purchase | +10K | $0.48 | $4.77K | 7.0% | 142.35K | 152.35K |
| Total | +10K | $4.77K | ||||||
Derivative Transactions0
No derivative transactions reported